Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415).Bozorgmehr F, Chung I, Fischer JR, et al. Clin Exp Metastasis. 2025 Jul 24;42(5):42. DOI: 10.1007/s10585-025-10358-x. PMID: 40702361; PMCID: PMC…